Pfizer Inc. buy BMO Capital Markets
Start price
02.05.24
/
50%
€25.92
Target price
02.05.25
€33.67
Performance (%)
6.36%
Price
22:26
€27.18
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 6.36%. A total of €0.39 was paid as dividends for this prediction. This prediction currently runs until 02.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pfizer Inc. | 1.796% | 1.796% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $36.00 price target on the stock, up previously from $33.00.
Ratings data for PFE provided by MarketBeat